Business
Niowave to supply Ac-225 for Ratio radiotherapy work
The agreement gives Ratio Therapeutics another cGMP Actinium-225 source for ongoing clinical trial activity and future targeted radiotherapeutic programs.
Company
Ratio Therapeutics
Business
Idaho Falls site added to RTX-2358 manufacturing plan
PharmaLogic will expand production capacity for Ratio Therapeutics’ Ac-225 RTX-2358 as the FAP-targeted radiopharmaceutical moves through ATLAS clinical testing.